STOCK TITAN

BCAR (Nasdaq: BCAR) sets July 29 shareholder vote for Exascale merger

(High)
(Neutral)
Form Type
425

Rhea-AI Filing Summary

D. Boral ARC Acquisition I Corp. furnished an 8-K reporting that the registrant and Exascale scheduled an Extraordinary General Meeting to vote on the previously announced Business Combination. The Meeting is set for July 29, 2026 at 10:00 AM Eastern Time. Shareholders of record as of July 6, 2026 are eligible to attend and vote. The Meeting will be held in person at Loeb & Loeb LLP in New York and virtually at www.proxydocs.com/BCAR. The filing states that a Registration Statement on Form S-4 (File No. 333-297214) has been filed and that the definitive proxy statement/prospectus has been mailed to shareholders.

Positive

  • None.

Negative

  • None.

Insights

Scheduling of shareholder vote advances the merger timetable.

The filing confirms an Extraordinary General Meeting on July 29, 2026 and a record date of July 6, 2026, reflecting standard proxy solicitation steps toward closing the Business Combination.

Key dependencies include satisfaction of closing conditions stated in the Form S-4 and shareholder approval; subsequent SEC filings or disclosures will show material updates.

The company has furnished the joint press release and proxy materials per solicitation rules.

The Form 8-K furnishes a press release (Exhibit 99.1) and references the definitive proxy statement/prospectus included in the Form S-4 (File No. 333-297214), indicating materials have been distributed to shareholders.

Shareholder voting mechanics are described: in-person and virtual attendance options and proxy card instructions; timing and results will be disclosed in subsequent filings.

Meeting date July 29, 2026 Extraordinary General Meeting to approve the Business Combination
Record date July 6, 2026 Shareholders of record eligible to vote at the Meeting
Form S-4 file number File No. 333-297214 Registration Statement on Form S-4 including the proxy statement/prospectus
Filing date July 7, 2026 Date of this Current Report on Form 8-K
Meeting time 10:00 AM Eastern Time Start time for the Extraordinary General Meeting
Business Combination financial
"entered into an Agreement and Plan of Merger by and among BCAR, PubCo, Merger Sub and Exascale"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.
proxy statement/prospectus regulatory
"Registration Statement on Form S-4 (File No. 333-297214), which includes the Proxy Statement of BCAR and a prospectus"
A proxy statement or prospectus is a document that companies send to shareholders to provide important information about upcoming decisions or investments, such as voting on company issues or offering new shares to the public. It helps investors understand the details and risks involved, enabling them to make informed choices about their ownership or involvement with the company.
Registration Statement on Form S-4 regulatory
"BCAR, Exascale and Pubco have filed relevant materials with the SEC, including a Registration Statement on Form S-4 (File No. 333-297214)"
A registration statement on Form S-4 is a formal filing with the U.S. Securities and Exchange Commission used when a company issues shares or other securities as part of a merger, acquisition, exchange offer or similar corporate deal. It bundles the transaction terms, financial statements, risk factors and shareholder vote materials so investors can assess the deal; think of it as a detailed prospectus or buyer’s packet that explains what you would own and how the deal could change your stake.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What is BCAR (BCAR) asking shareholders to approve at the July 29, 2026 meeting?

BCAR is asking shareholders to approve the Agreement and Plan of Merger to effect the Business Combination. The definitive proxy statement/prospectus accompanies the Form S-4 (File No. 333-297214) and was mailed to shareholders of record for voting.

Who is eligible to vote at BCAR's Extraordinary General Meeting on July 29, 2026?

Shareholders of record as of July 6, 2026 are eligible to attend and vote at the Meeting. The 8-K states that shareholders of record on that date received proxy materials and instructions to vote in person or virtually.

Where and how can BCAR shareholders attend the July 29, 2026 meeting?

The Meeting will be held at Loeb & Loeb LLP, 345 Park Avenue, New York, NY and virtually at www.proxydocs.com/BCAR. Shareholders can use the meeting instructions provided on their proxy cards to attend and vote.

Where can I find the proxy statement and Form S-4 for the BCAR–Exascale transaction?

Copies are available free on the SEC website or by request from BCAR and Exascale at the addresses in the filing. The Registration Statement is Form S-4, File No. 333-297214, which includes the definitive proxy statement/prospectus.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 7, 2026

 

 

 

D. Boral ARC Acquisition I Corp.

(Exact name of registrant as specified in its charter)

 

 

 

British Virgin Islands   001-42772   N/A

(State or other jurisdiction of

incorporation or organization)

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

10 East 53rd Street, Suite 3001

New York, NY 10022

(Address of principal executive offices, including zip code)

 

+ (332) 266-7344

(Registrant’s telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant   BCARU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   BCAR   The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share   BCARW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b‑2 of the Securities Exchange Act of 1934.

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01. Other Events.

 

As previously announced, on January 11, 2026, D. Boral ARC Acquisition I Corp. (“BCAR”) entered into an Agreement and Plan of Merger by and among BCAR, D. Boral ARC Merger Corporation, a Delaware corporation and wholly owned subsidiary of BCAR (“PubCo”), D. Boral Arc Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of BCAR, and Exascale Labs Inc., a Delaware corporation (“Exascale”) (collectively the “Business Combination”). On July 7, 2026, Exascale issued a press release announcing the scheduling of an Extraordinary General Meeting (the “Meeting”) of BCAR shareholders to approve the Agreement and Plan of Merger and related matters for July 29, 2026 at 10:00 AM Eastern Time. BCAR shareholders of record as of Monday, July 6, 2026, are eligible to attend and vote at the Meeting. The Meeting will be held at the offices of Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154 and virtually by visiting www.proxydocs.com/BCAR. BCAR shareholders can attend using the meeting instructions set forth on their proxy cards.

 

Furnished as Exhibit 99.1 hereto and incorporated into this Item 8.01 by reference is the joint press release that Exascale and BCAR issued to announce the scheduling of the Meeting.

 

The information in this Item 8.01, including Exhibit 99.1, is being furnished and will not be deemed to be filed for purposes of Section 18 of the Securities Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act or Exchange Act.

 

Forward Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as “anticipate,” “believe,” “can,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “will,” and similar expressions. These statements include, without limitation, statements regarding the proposed Business Combination, the expected timing and completion of the Business Combination, the operation of PubCo as Exascale Labs Holdings Inc., and the listing of its securities on Nasdaq under the ticker “XLAB.” They also include statements regarding AI infrastructure technologies, the expected demand for AI compute infrastructure, Exascale’s market positioning, and its business strategy, partnerships, and growth.

 

These statements are based on current expectations and assumptions, and involve risks and uncertainties that could cause actual results or events to differ materially, including, among others, the ability to complete the Business Combination and satisfy closing conditions, changes in customer demand, supply constraints for GPUs and related infrastructure components, competitive pressures, technological risks, operational performance, regulatory changes, and macroeconomic factors.

 

If any of these risks materialize or the assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither BCAR nor Exascale presently know or can anticipate or that BCAR and Exascale currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect BCAR’s, Exascale’s and PubCo’s expectations, plans or forecasts of future events and views as of the date of this press release. BCAR, Exascale and PubCo anticipate that subsequent events and developments will cause BCAR’s, Exascale’s and PubCo’s assessments to change. However, while BCAR, Exascale and PubCo may elect to update these forward-looking statements at some point in the future, BCAR, Exascale and PubCo specifically disclaim any obligation to do so. Readers are referred to the most recent reports filed with the United States Securities & Exchange Commission (“SEC”) by BCAR. Readers are cautioned not to place undue reliance upon any forward-looking statements. 

 

1

 

 

Additional Information

 

BCAR, Exascale and Pubco have filed relevant materials with the SEC, including a Registration Statement on Form S-4 (File No. 333-297214), which includes the Proxy Statement of BCAR and a prospectus in connection with Business Combination, referred to as a proxy statement/prospectus. The definitive Proxy Statement and other relevant documents have been mailed to shareholders of BCAR as of a record date established for voting on the proposed Business Combination. SHAREHOLDERS OF BCAR AND OTHER INTERESTED PARTIES ARE URGED TO READ THE REGISTRATION STATEMENT, THE DEFINITIVE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH BCAR’S SOLICITATION OF PROXIES FOR THE EXTRAORDINARY GENERAL MEETING OF ITS SHAREHOLDERS TO BE HELD TO APPROVE THE BUSINESS COMBINATION BECAUSE THESE DOCUMENTS CONTAINS OR WILL CONTAIN IMPORTANT INFORMATION ABOUT BCAR, EXASCALE, PUBCO AND THE BUSINESS COMBINATION. Shareholders can obtain copies of the Registration Statement and the proxy statement/prospectus, without charge, on the SEC’s website at www.sec.gov or by directing a request to: D. Boral ARC Acquisition I Corp., 10 East 53rd Street, Suite 3001, New York, NY 10022; or Exascale, 820 Gessner Road, Suite 332 Houston, TX 77024. 

 

Participants in the Solicitation

 

Exascale, BCAR and PubCo and their respective directors and executive officers may be deemed under SEC rules to be participants in the solicitation of proxies from BCAR’s shareholders in connection with the Business Combination. A list of the names of such directors and executive officers, and information regarding their interests in the Business Combination and their ownership of BCAR’s and/or PubCo’s securities are contained in the Registration Statement and the Proxy Statement. Information about BCAR’s directors and executive officers is also available in BCAR’s filings with the SEC. You may obtain free copies of these documents from the sources described above. 

 

No Offer or Solicitation

 

This Current Report on Form 8-K is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Business Combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction where such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

2

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1*   Press Release, dated July 7, 2026
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 
* Furnished but not filed.

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 7, 2026  
   
D. BORAL ARC ACQUISITION I CORP.  
   
By: /s/ John Darwin  
Name:  John Darwin  
Title:  Chief Financial Officer  

 

4